Medicine and Dentistry

1. Patient 100%
2. Positron Emission Tomography 37%
3. Combination Therapy 37%
4. Recurrent Disease 34%
5. Biological Marker 32%
6. Bladder Cancer 29%
7. Prostatectomy 29%
8. Non Muscle Invasive Bladder Cancer 26%
9. Lymphocyte 24%
10. Prostate Cancer 24%
11. Gallium 68 23%
12. Inpatient 21%
13. Biochemical Recurrence 18%
14. Neutrophil 18%
15. Lymph Node 18%
16. Lesion 16%
17. Transitional Cell Carcinoma 16%
18. Analysis 15%
19. Association 14%
20. Accuracy 14%
21. Histology 13%
22. Diagnosis 13%
23. Magnetic Resonance Imaging 12%
24. Radiation Therapy 12%
25. Germinoma 12%
26. Prostate Specific Membrane Antigen 12%
27. Cancer 12%
28. Muscle Invasive Bladder Cancer 12%
29. Systemic Therapy 12%
30. Body Mass Index 12%
31. Diagnostic Performance 11%
32. Overall Survival 11%
33. Surgery 11%
34. Diseases 10%
35. Computed Tomography 9%
36. Risk Stratification 9%
37. Survival 9%
38. Follow up 9%
39. Radioligand 9%
40. Morphology 9%
41. Prostate Specific Antigen 9%
42. Development 9%
43. Malignant Neoplasm 8%
44. Seasonal Variation 8%
45. Decision Making 8%
46. Tissues 8%
47. Cancer Prognosis 8%
48. Randomized Controlled Trial 8%
49. Diet 8%
50. Castration Resistant Prostate Cancer 8%